News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,889 Results
Type
Article (25747)
Company Profile (69)
Press Release (351073)
Section
Business (104191)
Career Advice (448)
Deals (16866)
Drug Delivery (47)
Drug Development (47524)
Employer Resources (47)
FDA (12234)
Job Trends (8423)
News (185753)
Policy (19389)
Tag
Academia (1730)
Alliances (26644)
Alzheimer's disease (754)
Approvals (12243)
Artificial intelligence (110)
Bankruptcy (137)
Best Places to Work (6878)
Breast cancer (142)
Cancer (988)
Cardiovascular disease (85)
Career advice (407)
Cell therapy (152)
Clinical research (39828)
Collaboration (314)
Compensation (75)
COVID-19 (1466)
C-suite (81)
Data (1015)
Diabetes (120)
Diagnostics (3406)
Earnings (36147)
Events (50884)
Executive appointments (310)
FDA (12849)
Funding (278)
Gene therapy (87)
GLP-1 (340)
Government (2999)
Healthcare (12155)
Infectious disease (1517)
Inflammatory bowel disease (69)
IPO (6996)
Job creations (1836)
Job search strategy (377)
Layoffs (155)
Legal (3617)
Lung cancer (169)
Lymphoma (66)
Manufacturing (78)
Medical device (12759)
Medtech (12762)
Mergers & acquisitions (10033)
Metabolic disorders (309)
Neuroscience (975)
NextGen: Class of 2025 (3927)
Non-profit (2818)
Northern California (973)
Obesity (175)
Opinion (64)
Parkinson's disease (64)
Patents (69)
People (34322)
Phase I (11410)
Phase II (17248)
Phase III (14154)
Pipeline (344)
Postmarket research (1668)
Preclinical (3544)
Radiopharmaceuticals (158)
Rare diseases (139)
Real estate (2841)
Regulatory (13868)
Research institute (1600)
Southern California (843)
Startups (2118)
United States (9360)
Vaccines (302)
Weight loss (119)
Date
Today (95)
Last 7 days (269)
Last 30 days (1124)
Last 365 days (19593)
2025 (1064)
2024 (19857)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32194)
2019 (28414)
2018 (21811)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Arizona (98)
Asia (24229)
Australia (3833)
California (2177)
Canada (945)
China (250)
Colorado (124)
Connecticut (128)
Delaware (75)
Europe (47246)
Florida (381)
Georgia (92)
Illinois (281)
Indiana (174)
Japan (68)
Kansas (68)
Maryland (502)
Massachusetts (1556)
Michigan (83)
Minnesota (215)
New Jersey (778)
New York (669)
North Carolina (449)
Northern California (973)
Ohio (99)
Pennsylvania (613)
South America (519)
Southern California (843)
Texas (373)
Utah (76)
Washington State (172)
376,889 Results for "xtant medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Xtant Medical Reports Third Quarter 2024 Financial Results
November 12, 2024
·
15 min read
BioForest
Xtant Medical Announces Launch of SimpliGraft™ and SimpliMax™ for Chronic and Acute Wounds
Xtant Medical Holdings, Inc. announced the full commercial launch of two amniotic membrane allografts, SimpliGraft™ and SimpliMax™.
April 30, 2024
·
4 min read
Press Releases
Xtant Medical to Attend the 15th Annual Craig-Hallum Alpha Select Conference
November 11, 2024
·
4 min read
Press Releases
Xtant Medical to Issue Third Quarter 2024 Financial Results on November 12, 2024
November 7, 2024
·
1 min read
Business
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Xtant Medical Holdings, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024.
May 8, 2024
·
1 min read
Xtant Medical to Participate in Upcoming Investor Conferences
Xtant Medical Holdings, Inc. today announced that management will participate in two upcoming investor conferences.
February 5, 2024
·
1 min read
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Xtant Medical Holdings, Inc. today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will participate in the 21st Annual Craig-Hallum Institutional Investor Conference on May 29 in Minneapolis.
May 22, 2024
·
1 min read
Business
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal disorders, reported financial and operating results for the first quarter ended March 31, 2024.
May 15, 2024
·
13 min read
Business
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Xtant Medical Holdings, Inc. reported financial and operating results for the fourth quarter and year ended December 31, 2023.
April 1, 2024
·
13 min read
BioForest
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
Xtant Medical Holdings, Inc. announced that the Company’s revolving credit agreement with MidCap Financial Trust was amended to increase the commitment from $8.0 million to $17.0 million.
March 7, 2024
·
4 min read
1 of 37,689
Next
